Consensus Acticor Biotech SAS

Equities

ALACT

FR0014005OJ5

End-of-day quote Euronext Paris Other stock markets 06:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
0.892 ^EUR	-3.04%		-21.75%	-69.24%

May. 15	Acticor: 'new perspectives' in stroke treatment	CF
May. 15	Acticor Biotech Announces Presentation of the Main Results of the Phase 2/3 Actisave Study in the Treatment of Stroke at ESOC 2024	CI

Evolution of the average Target Price on Acticor Biotech SAS

Price target over the last 5 years

History of analyst recommendation changes

f93491d99d7bedc2f71280fc6a247d4.vgQUzX3OXCYL29-h95bBbyKQq4buHihRf6Krz4fMd04.i0ZanhqbK1Zjjpv4pLuNOEnk4_KKKxgaFPv__sqUIh3mVCa9NZYZfm6d5w~fd33b393dbd7131a46ec87f4df131007

Analysts' Consensus

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

0.892 EUR

Average target price

1 EUR

Spread / Average Target

+12.11%

High Price Target

1 EUR

Spread / Highest target

+12.11%

Low Price Target

1 EUR

Spread / Lowest Target

+12.11%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar